Madeline Donato Burgos, APRN-BC

Madeline Burgos practices at Helen F Graham Cancer Center & Research Institute in Newark, Delaware.

Madeline Burgos' NPI, 1245563964, was assigned on September 14, 2009. Madeline Burgos holds Delaware license LH-0000191.

Madeline Burgos' primary practice is Helen F Graham Cancer Center & Research Institute, at 200 Hygeia Dr, Newark, DE 19713 in New Castle County. The practice phone is (302) 623-4285.

Madeline Burgos' primary practice is Helen F Graham Cancer Center & Research Institute in Newark, Delaware. Madeline Burgos is also affiliated with Christiana Hospital. The medical group on file is ChristianaCare. Dmand AI also links Madeline Burgos to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Madeline Burgos practices, 6 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Madeline Burgos' primary specialty in the NPI Registry, under taxonomy code 363L00000X. Madeline Burgos is licensed in Delaware.

CMS counts 145 Medicare patients who saw Madeline Burgos in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Madeline Burgos' median patient age at 70, with 99% women.

In 2024, Madeline Burgos wrote 250 Medicare Part D claims for 79 patients. 82% of them were for generic drugs.

Madeline Burgos accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Madeline Burgos as offering telehealth.

CMS Open Payments shows 2 general payments to Madeline Burgos from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Eisai Inc. paid the most, $110.